Cobra Biologics and Pharmaceutical Services Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ DNA, Viral Vector and Microbiota products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities. Latest News View all Cognate BioServices announces acquisition of Cobra Biologics 4th Nov 2019 CPI Accelerates Gene Therapy Development with Robust Adeno-Associated Virus Purification System in Partnership with Cobra Biologics and GE Healthcare 24th Oct 2019 CombiGene signs agreement with Cobra Biologics for production of candidate drug CG01 14th Oct 2019 HQ Plasmid Slots Now Available Our High Quality (HQ) offering adopts features of Cobra’s GMP manufacture with a 6 week delivery time. Find Out More & Get In Touch Today Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products. Find Out More Our Awards Get In Touch Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden. Contact Us About Cobra Biologics Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. 2 GMP approved facilities 320+ products released for clinical trials 18 Countries serviced Sign up to receive news and more Keep up to date with the latest news from Cobra Biologics Newsletter signup Name Email
CPI Accelerates Gene Therapy Development with Robust Adeno-Associated Virus Purification System in Partnership with Cobra Biologics and GE Healthcare 24th Oct 2019